CJC-1295 No DAC 10mg / Ipamorelin 5mg – 15mg (Blend) Product Information
The combination of CJC-1295 and Ipamorelin is examined in laboratory research as a dual-pathway approach to growth hormone signaling regulation within non-human experimental models. CJC-1295 is a synthetic GHRH-analog research peptide characterized by prolonged signaling persistence, attributed to its affinity for circulating proteins, which supports sustained engagement of growth hormone–associated signaling pathways under controlled conditions. Ipamorelin is studied alongside CJC-1295 for its role in ghrelin-related receptor signaling, allowing researchers to evaluate coordinated pituitary-adjacent pathway behavior and pulsatile signaling dynamics relevant to growth hormone regulatory frameworks. When examined together, these compounds provide a structured model for investigating signal amplitude patterns, temporal release coordination, and endocrine signaling architecture in non-human research systems. This peptide pairing is frequently utilized in studies focused on growth hormone regulatory mechanisms, cellular signaling adaptation, and system-level endocrine coordination, offering researchers a controlled platform for exploring regenerative-adjacent signaling models and hormone-linked pathway integration strictly within laboratory research environments. Summary of Characteristics Attribute CJC-1295 Ipamorelin Chemical Sequence Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu Aib-His-D-2-Nal-D-Phe-Lys-NH2 Molecular Formula C165H269N47O46 C38H49N9O5 Molecular Weight 3647.19 g/mol 711.85 g/mol Other Known Titles GHRH-Associated Research Peptide, Growth Hormone Signaling Research Analog Ghrelin-Associated Research Peptide, GH Signaling Modulation Research Compound
